Clinical trial

Omega-3 Fatty Acid Lipidomics in Diabetes Peripheral Neuropathy

NCT05169060

StatusACTIVE_NOT_RECRUITING

Study typeINTERVENTIONAL

Start date2023-06-12

PhasePHASE1 / PHASE2

Study timeline

Study start (actual)2023-06-12Date precision: day

Registry last updated2026-04-06

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Diabetic Neuropathiesunresolved

Interventions

Fish Oil Concentrate, 1000 Mg Oral CapsuleDRUG

Salsalate Oral TabletDRUG · verified · RxNorm: salsalate Oral Tablet

Sponsors & collaborators

University of Iowalead sponsor

University of Michigancollaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)collaborator

Oregon Health and Science Universitycollaborator

Mapped research locations

PortlandOregon, United States1 Iowa CityIowa, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT05169060 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.